Stryker Net Income 2006-2018 | SYK

Stryker annual/quarterly net income history and growth rate from 2006 to 2018. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Stryker net income for the quarter ending December 31, 2018 was $2.068B, a 930.52% decline year-over-year.
  • Stryker net income for the twelve months ending December 31, 2018 was $3.553B, a 248.33% increase year-over-year.
  • Stryker annual net income for 2018 was $3.553B, a 248.33% increase from 2017.
  • Stryker annual net income for 2017 was $1.02B, a 38.07% decline from 2016.
  • Stryker annual net income for 2016 was $1.647B, a 14.45% increase from 2015.
Stryker Annual Net Income
(Millions of US $)
2018 $3,553
2017 $1,020
2016 $1,647
2015 $1,439
2014 $515
2013 $1,006
2012 $1,298
2011 $1,345
2010 $1,273
2009 $1,107
2008 $1,148
2007 $1,017
2006 $778
2005 $644
Stryker Quarterly Net Income
(Millions of US $)
Q4 2018 $2,068
Q3 2018 $590
Q2 2018 $452
Q1 2018 $443
Q4 2017 $-249
Q3 2017 $434
Q2 2017 $391
Q1 2017 $444
Q4 2016 $510
Q3 2016 $355
Q2 2016 $380
Q1 2016 $402
Q4 2015 $522
Q3 2015 $301
Q2 2015 $392
Q1 2015 $224
Q4 2014 $260
Q3 2014 $57
Q2 2014 $128
Q1 2014 $70
Q4 2013 $386
Q3 2013 $103
Q2 2013 $213
Q1 2013 $304
Q4 2012 $270
Q3 2012 $353
Q2 2012 $325
Q1 2012 $350
Q4 2011 $401
Q3 2011 $327
Q2 2011 $310
Q1 2011 $307
Q4 2010 $295
Q3 2010 $337
Q2 2010 $319
Q1 2010 $322
Q4 2009 $306
Q3 2009 $229
Q2 2009 $291
Q1 2009 $281
Q4 2008 $278
Q3 2008 $274
Q2 2008 $306
Q1 2008 $291
Q4 2007 $276
Q3 2007 $229
Q2 2007 $269
Q1 2007 $244
Q4 2006 $228
Q3 2006 $188
Q2 2006 $214
Q1 2006 $148
Q4 2005 $178
Q3 2005 $121
Q2 2005 $178
Q1 2005 $167
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $67.256B $13.601B
Stryker Corporation is one of the world's leading medical technology companies and together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $129.838B 25.32
Medtronic (MDT) Ireland $112.952B 16.51
Boston Scientific (BSX) United States $48.820B 23.72
Baxter (BAX) United States $37.991B 24.37
Zimmer Biomet Holdings (ZBH) United States $24.550B 15.71
Smith & Nephew SNATS (SNN) United Kingdom $16.615B 0.00
Canopy Growth (CGC) Canada $14.912B 0.00
ResMed (RMD) United States $14.218B 26.96
Aurora Cannabis (ACB) Canada $9.118B 64.29
Bio-Rad Laboratories (BIO) United States $8.765B 50.28
Perrigo (PRGO) Ireland $6.633B 10.75
Hill-Rom Holdings (HRC) United States $6.374B 19.72
Insulet (PODD) United States $4.900B 1642.60
GW Pharmaceuticals (GWPH) United Kingdom $4.701B 0.00
ICU Medical (ICUI) United States $4.568B 28.29
Haemonetics (HAE) United States $4.189B 37.16
Hutchison China MediTech (HCM) China $4.046B 0.00
Agios Pharmaceuticals (AGIO) United States $3.268B 0.00
Neogen (NEOG) United States $2.958B 48.10
NuVasive (NUVA) United States $2.784B 24.18
Quidel (QDEL) United States $2.365B 21.17
National Vision Holdings (EYE) United States $2.220B 43.66
Aphria (APHA) $1.917B 0.00
Phibro Animal Health (PAHC) United States $1.349B 19.38
VAREX IMAGING (VREX) United States $1.222B 23.93
Cardiovascular Systems (CSII) United States $1.190B 854.00
AtriCure (ATRC) United States $1.049B 0.00
Lantheus Holdings (LNTH) United States $0.931B 25.16
Omeros (OMER) United States $0.908B 0.00
PetIQ (PETQ) United States $0.862B 24.67
MacroGenics (MGNX) United States $0.791B 0.00
Cerus (CERS) United States $0.787B 0.00
NanoString Technologies (NSTG) United States $0.737B 0.00
TG Therapeutics (TGTX) United States $0.689B 0.00
Evolus (EOLS) United States $0.681B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.666B 22.66
OraSure Technologies (OSUR) United States $0.594B 25.86
Surmodics (SRDX) United States $0.546B 79.43
LeMaitre Vascular (LMAT) United States $0.536B 25.46
Meridian Bioscience (VIVO) United States $0.531B 15.82
Quanterix (QTRX) United States $0.492B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.322B 0.00
Utah Medical Products (UTMD) United States $0.321B 20.88
Insys Therapeutics (INSY) United States $0.313B 0.00
BioLife Solutions (BLFS) United States $0.305B 125.85
Vapotherm (VAPO) United States $0.296B 0.00
Rockwell Medical (RMTI) United States $0.271B 0.00
Cytosorbents (CTSO) United States $0.219B 0.00
Owens & Minor (OMI) United States $0.213B 2.91
Zynex (ZYXI) United States $0.171B 18.31
Chimerix (CMRX) United States $0.133B 0.00
Bovie Medical (APYX) United States $0.131B 0.00
Fonar (FONR) United States $0.125B 6.68
Chembio Diagnostics (CEMI) United States $0.121B 0.00
Surface Oncology (SURF) United States $0.113B 0.00
Female Health (VERU) United States $0.088B 0.00
United-Guardian (UG) United States $0.088B 20.06
CAS Medical Systems (CASM) United States $0.072B 0.00
Neurotrope (NTRP) United States $0.071B 0.00
Trinity Biotech (TRIB) Ireland $0.071B 21.00
Oramed Pharmaceuticals (ORMP) United States $0.070B 0.00
GUARDION HEALTH (GHSI) United States $0.057B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Senestech (SNES) United States $0.034B 0.00
Valeritas Holdings (VLRX) United States $0.031B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.025B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 13.71